University College London | Centre for Clinical Microbiology
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to determine if an investigational drug can prevent Bronchopulmonary Dysplasia, reducing the burden of chronic lung disease in extremely premature infants, as compared to extremely premature infants receiving standard neonatal care alone.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
338 participants in 2 patient groups
Loading...
Central trial contact
OHB Contact
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal